Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pegylated opioid-like substance having low addiction effect

An opioid and polyethylene glycol technology, which can be applied to medical preparations without active ingredients, medical preparations containing active ingredients, and organic active ingredients, etc., can solve the problem of reducing the affinity between opioids and opioid receptors , reduce drug addiction and other problems

Active Publication Date: 2017-08-08
JENKEM TECH
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the above-mentioned opioid-polyethylene glycol conjugates have reduced drug addiction, however, the affinity between opioids and opioid receptors decreases significantly as the molecular weight of the polymer increases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pegylated opioid-like substance having low addiction effect
  • Pegylated opioid-like substance having low addiction effect
  • Pegylated opioid-like substance having low addiction effect

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0110] Embodiment 1: prepare PEG n -(OMs) 2

[0111] Add diethylene glycol (10.0 g, 94.3 mmol) and dichloromethane (100 mL) into a 250 mL three-necked flask, stir and cool to 0°C. Triethylamine (19.1 g, 188.6 mmol) was added dropwise, and the reaction mixture was stirred for 10 minutes. Methanesulfonyl chloride (21.6 g, 188.6 mmol) was added to the reaction mixture over 5-10 minutes, stirred at room temperature for 12 hours, and the progress of the reaction was monitored by TLC. After the reaction was complete, distilled water was added to the reaction mixture, followed by extraction with dichloromethane (3×100 mL). The organic layers were combined, washed with distilled water (3×100 mL), dried over anhydrous sodium sulfate, and concentrated to dryness with a rotary evaporator under reduced pressure to obtain 21.8 g of a brown oil with a yield of 88.2%. 1 H NMR (400MHz, CDCl 3 ): δ4.10(t,4H), 3.86(t,4H), 3.19(s,6H).

[0112] Prepare other MsO-PEG in the same way n -OMs ...

Embodiment 2

[0113] Embodiment 2: Preparation of PEG n -(morphine) 2 Conjugate

[0114]

[0115] Step 1: Preparation of 3-O-MEM-morphine (2)

[0116] Morphine sulfate (1.00 g, 2.64 mmol) was dissolved in acetone / toluene (70 mL / 35 mL) at room temperature, and the mixture was stirred homogeneously. Add K to the mixture 2 CO 3 (1.35g, 9.77mmol), stirred for 25 minutes, then added MEMCl (0.66g, 5.28mmol). The reaction mixture was stirred at room temperature for 24 hours, then quenched by the addition of anhydrous methanol (1.2 mL). The reaction mixture was concentrated to dryness under reduced pressure, distilled water (15 mL) and saturated brine (45 mL) were added to the residue, and extracted with ethyl acetate (3×50 mL). The combined organic solution was washed with saturated brine (3×50 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by Biotage flash purification preparative liquid chromatography to obtain 0.52 g of a l...

Embodiment 3

[0121] Embodiment 3: preparation PEG n -(codeine) 2 Conjugate

[0122]

[0123] Step 1: Preparation of 6-O-PEG n -(codeine) 2 Free base (6)

[0124] Add codeine (2.4-2.8 equivalents) to a mixed solution of toluene / DMF (24 times / 1 times volume), followed by NaH (8-12 times equivalents), and then PEG n -(OMs) 2 . The reaction mixture was heated to 45-65° C. and kept stirring until the completion of the reaction was confirmed by LC-MS analysis (12-48 hours depending on PEG chain length). The reaction was terminated with anhydrous methanol (10 volumes), and the reaction mixture was concentrated to dryness under reduced pressure. The residue was purified by Biotage flash preparative liquid chromatography to obtain a yellow to orange oil with a yield of 12 to 25%. 6-O-PEG was prepared by this method n -(codeine) 2 Free base (n=1, 2, 3, 4, 5, 6, 7, 8, 9), the product is 1 Confirmed by H NMR and LC-MS.

[0125] Step 2: Preparation of 6-O-PEG n -(codeine) 2 Hydro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a polyethylene glycol and opioid-like substance conjugate shown as general formula (I) (as shown in Description) and a pharmaceutical composition containing the conjugate. By bonding a plurality of opioid-like substance to polyethylene glycol derivatives in a covalent mode, water solubility and pharmacokinetic properties of drugs are improved; and a low addiction effect is achieved.

Description

technical field [0001] The present invention relates to hydrophilic polymer opioid conjugates, especially pegylated opioids with low addictive effects and pharmaceutical compositions thereof. Background technique [0002] Opioids (also known as opioid receptor agonists, such as morphine, codeine, etc.) have a strong analgesic effect and have been widely used in clinical practice as analgesics. They interact with opioid receptors (including μ receptors, κ receptors and δ receptors, especially μ receptors and κ receptors) interact to produce analgesic effects. [0003] However, repeated administration of opioids during nerve analgesia may cause drug resistance and physiological dependence (ie, addiction). Addiction is the main problem when opioids are used for analgesia. There is a euphoric effect when the drug is used, and the discomfort caused after stopping the drug (such as anorexia, weight loss, anxiety, irritability, dizziness, abdominal pain, vomiting, cramps, runny no...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/60A61K31/485A61K31/4468A61P25/04
CPCA61K31/4468A61K31/485A61K47/60A61K47/55A61P25/04A61P25/36
Inventor 冯泽旺汪进良刘岩赵宣
Owner JENKEM TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com